drugset / Trial / NCT02742675

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

NCT02742675

Phase 2 Unknown 200 enrolled Fudan University
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical research is to learn if treatment with androgen deprivation therapy in combination with surgery or radiation therapy can prolong the progression-free survival of oligometastatic prostate cancer than androgen deprivation therapy alone. The safety of this treatment combination will also be studied.

Timeline

Start
2015-09
Primary completion
2021-03
Completion
2023-03

Drugs

EvaluationDrugModalityDoseRoute
Background Bicalutamide Other / unclassified Oral
Background Goserelin Other / unclassified Subcutaneous
Background Leuprolide Other / unclassified Subcutaneous
Background Triptorelin Other / unclassified Subcutaneous
Background flutamide Small molecule Oral

Indications